Please use this identifier to cite or link to this item:
http://dspace.mediu.edu.my:8181/xmlui/handle/10261/4304| Title: | Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis |
| Keywords: | Atherosclerosis Restenosis Diabetes Mellitus Irs Metabolic Syndrome Genetically-Modified Mice Insulin Resistance Chronic Inflammation Hypercholesterolemia Review |
| Publisher: | Frontiers in Bioscience Publications |
| Description: | This is an, un-copyedited, author manuscript that has been accepted for publication in the Frontiers in Bioscience Atherosclerosis and related forms of cardiovascular disease (CVD) are associated with several genetic and environmental risk factors, including hypercholesterolemia, diabetes mellitus (DM), hypertension, obesity and smoking. Human DM is a multisystem disorder that results from progressive failure of insulin production and insulin resistance. Most diabetic patients die from complications of atherosclerosis and CVD, and DM is also associated with increased risk of restenosis post-angioplasty. Furthermore, the incidence of DM, particularly type 2-DM, is expected to increase significantly during the next decades owing to the unhealthy effects of modern life-style habits (e.g., obesity and lack of physical exercise). Thus, it is of utmost importance to develop novel preventive and therapeutic strategies to reduce the social and health-care burden of CVD and DM. Although a number of physiological alterations thought to promote atherosclerosis have been identified in diabetic patients, the precise molecular mechanisms that link DM and atherosclerosis are largely unknown. Thus, the aim of this review is to discuss current murine models of combined DM and atherosclerosis and to explore how these experimental systems are being utilized to gain mechanistic insights into diabetes-induced neointimal lesion development, as well as their potential use in evaluating the efficacy of new therapies. Our discussion includes models generated by streptozotocin treatment and those resulting from naturally occurring or targeted mutations in the mouse. Work in the laboratory of the authors is supported by grants from the Spanish Instituto de Salud Carlos III (Red Temática de Investigación Cooperativa en Enfermedades Cardiovasculares RECAVA, Red de Grupos G03/212), and from the Spanish Ministry of Education and Science and the European Regional Development Fund (SAF2004-03057, SAF2005-06058). H. G.-N. is supported by an European Union Marie Curie postdoctoral fellowship. Peer reviewed |
| URI: | http://dspace.mediu.edu.my:8181/xmlui/handle/10261/4304 |
| Other Identifiers: | Frontiers in Bioscience 12, 4439-4455 http://hdl.handle.net/10261/4304 10.2741/2400 |
| Appears in Collections: | Digital Csic |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.